Business
Sofwave to Participate in 10th Annual Needham Virtual MedTech & Diagnostics Conference
SAN CLEMENTE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 10th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 11 – 12, 2025. About Sofwave MedicalSofwave Medical Ltd. has implemented an innovative
About this update from Sofwave Medical Ltd.
SAN CLEMENTE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, today announced that Louis Scafuri, Chief Executive Officer, and Assaf Korner, Chief Financial Officer, will participate in the 10 th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference on August 11 – 12, 2025. About Sofwave Medical Sofwave Medical Ltd. has implemented an innovative approach to wrinkle reduction lifting and cellulite using its proprietary breakthrough technology. SUPERB™, Synchronous Ultrasound Parallel Beam technology, is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow and lifting lax submental tissue (beneath the chin), to improve the appearance of skin laxity on the upper arms, as well as the short-term improvement in the appearance of cellulite and treatment of acne scars. The company’s Pure Impact™ module uses 4th generation EMS technology and is cleared for muscle toning. Sofwave’s products provide physicians with smart yet simple, effective, and safe aesthetic solutions for their patients. Contact: [email protected] Investor Contact: Brian Ritchie LifeSci Advisors LLC (212) 915-2578 [email protected]
View stock analysis, news, and events for Sofwave Medical Ltd.